Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD
Clinical trial NCT04786990 · COMPLETED
Trial details
- NCT number
- NCT04786990
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-27
- Primary completion
- 2023-05-23
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.